Vanessa Lickson
Family · Blountstown, FLNPI 1609343698
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $970, more than ten times the $96 reported in 2021.
Across 91 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascendis Pharma Endocrinology Inc$256
- Lilly USA, LLC$244
- AstraZeneca$240
- Novo Nordisk$176
- Amgen$157
- Novartis$96
- plus $712 from 23 others
What the payments were for
- Food & beverage$1,873100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 3 | $256 |
| Lilly USA, LLC | 15 | $244 |
| AstraZeneca(2 entities) | 14 | $240 |
| Novo Nordisk | 5 | $176 |
| Amgen | 10 | $157 |
| Novartis | 5 | $96 |
| GSK | 5 | $83 |
| Verona Pharma, Inc. | 3 | $59 |
| AbbVie | 3 | $56 |
| Abbott | 2 | $46 |
| Dexcom, Inc. | 2 | $45 |
| Exact Sciences | 2 | $39 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| Medtronic | 2 | $33 |
| Pfizer | 2 | $30 |
| Grifols USA, LLC | 2 | $29 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Almatica Pharma LLC | 1 | $22 |
| Boehringer Ingelheim | 1 | $19 |
| Tolmar, Inc. | 1 | $19 |
| Soleno Therapeutics, Inc. | 1 | $19 |
| Gilead | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Bayer | 1 | $18 |
| Sequel Med Tech, LLC | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Yorvipath$125
How this compares
$1,881 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 34 | $33,815 |
| FarxigaDapagliflozin Propanediol | 29 | $18,991 |
| MounjaroTirzepatide | 11 | $15,432 |
| JardianceEmpagliflozin | 16 | $11,773 |
| EliquisApixaban | 16 | $9,167 |
| ErythromycinErythromycin Base | 13 | $5,014 |
| Glipizide | 11 | $457 |
| Nebivolol Hcl | 12 | $443 |
| FenofibrateFenofibrate Nanocrystallized | 12 | $418 |
| Fluticasone Propionate | 35 | $401 |
| Omeprazole | 38 | $375 |
| Dutasteride | 13 | $369 |
| Rosuvastatin Calcium | 47 | $343 |
| Pantoprazole Sodium | 33 | $312 |
| Lisinopril | 57 | $264 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $244 | $49,24845 claims |
| AstraZenecaFarxiga | $240 | $18,99129 claims |
| Boehringer IngelheimJardiance | $19 | $11,77316 claims |
| PfizerEliquis | $30 | $9,16716 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $14 | $21637 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 14,618 family providers in Florida.
Other family in Blountstown
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.